Hos patienter, der udvikler reaktivering af HBV, bør Humira stoppes og effektiv anti- viral behandling med passende understøttende behandling bør initieres.
In patients who develop HBV reactivation, Humira should be stopped and effective anti- viral therapy with appropriate supportive treatment should be initiated.